UnknownPhase 2

RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy

China196 participantsStarted 2020-04-02

Plain-language summary

This is a multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of Chinese herbal compound in improving fatigue symptoms and quality of life in patients with chemotherapy.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Malignant tumor patients with pathological diagnosis * Men and women aged 18-75 * KPS score ≥ 70, expected survival time more than 6 months * The function of heart, lung, liver and kidney was normal * Hemoglobin ≥ 8g * Neuroendocrine function is normal * BMI ≥ 18.5. * Cancer pain, VAS score \< 3 * Fatigue score ≥ 4 * syndrome differentiation is deficiency of Qi and blood Exclusion Criteria: * Brain metastases with Symptomatic * Mental disease * Severe infection * Insomniacs * Pregnant or lactating women

What they're measuring

Fatigue score

Timeframe: 21 days

Trial details

NCT IDNCT05229029

SponsorPeking University Cancer Hospital & Institute

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-01

View on ClinicalTrials.gov More Cancer-related Problem/Condition trials